drugset / Trial / NCT01594437
Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the safety profile in healthy adult volunteers of single or multiple intravenous administrations of TCN-202 as compared with placebo.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-12
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TCN-202 | Monoclonal antibody | — | Intravenous |